WuXi XDC Reports Impressive Growth in 2025, Solidifying Its Position in Bioconjugate CRDMO Market WuXi XDC’s 2025 financial performance reflects significant growth in revenue and market position, underscoring its role in bioconjugate CRDMO.

WuXi XDC Reports Impressive Growth in 2025, Solidifying Its Position in Bioconjugate CRDMO Market #China #Shanghai #WuXi_XDC #bioconjugate #CRDMO

WuXi XDC Achieves Extraordinary Growth in 2024 with Record Financial Performance WuXi XDC celebrates significant milestones in 2024, reporting a remarkable 90.8% revenue increase driven by expanding customer base and innovative technologies, solidifying its leadership in the bioconjugate sector.

WuXi XDC Achieves Extraordinary Growth in 2024 with Record Financial Performance #China #Shanghai #ADC #WuXi_XDC #bioconjugate